Intellia Therapeutics Inc Capital Reinvestment Ratio
Intellia Therapeutics Inc capital reinvestment ratio. Intellia Therapeutics Inc (NTLA) has a Capital Reinvestment Ratio of 0.02x as of June 2020, meaning it reinvests 0% of its operating cash flow ($57.42 Million) in capital expenditures ($1.04 Million). Check Intellia Therapeutics Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Intellia Therapeutics Inc (2016–2016)
Capital reinvestment ratio of Intellia Therapeutics Inc from 2016 to 2016. This chart tracks Intellia Therapeutics Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore how fast is Intellia Therapeutics Inc growing its equity to track the company's year-over-year net asset growth rate.
Intellia Therapeutics Inc Capital Reinvestment Ratio by Year (2016–2016)
Intellia Therapeutics Inc capital reinvestment ratio by year from 2016 to 2016. For the full cash flow conversion analysis, see how efficiently does Intellia Therapeutics Inc generate cash.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.17x | $36.11 Million | $6.17 Million | — |